To verify that the robust response of CD8+ TRM cells against tumor cells is associated with the interaction between expanded TCR and MHC-I, MHC-I was blocked in vivo using an αMHC-I antibody when CD8+ TRM cells were transplanted into naïve mice. This evidence concerns the gene CD8A and neoplasm.